[Federal Register Volume 78, Number 26 (Thursday, February 7, 2013)]
[Notices]
[Page 9055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-02791]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial review

    The meeting announced below concerns Epidemiology, Prevention and 
Treatment of Influenza and other Respiratory Infections in Panama and 
Central America Region, Funding Opportunity Announcement (FOA) IP13-
002; and Strengthening Global Animal-Human Interface Activities for 
Avian Influenza and other Zoonotic Diseases, FOA CK13-002, initial 
review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 1:00 p.m.-3:00 p.m., March 28, 2013 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Epidemiology, Prevention and Treatment of Influenza 
and other Respiratory Infections in Panama and Central America 
Region, FOA IP13-002; and Strengthening Global Animal-Human 
Interface Activities for Avian Influenza and other Zoonotic 
Diseases, FOA CK13-002''.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-02791 Filed 2-6-13; 8:45 am]
BILLING CODE 4163-18-P